[Long-Term Elderly Survivor with Recurrent MSI-High Gastric Cancer Using Pembrolizumab as a Second-Line Chemotherapy]

Satoshi Hamada1, Shuhei Komatsu, Mizuki Nishiko

  • 1Dept. of Surgery, Kyoto First Red Cross Hospital.